At Close: 4:00 PM
Pre Market: 7:03 AM
Lipocine Stock Price Graph
Lipocine Stock Price Today
Lipocine Inc. (LPCN) stock declined over -13.22% intraday to trade at $4.66 a share on NASDAQ. The stock opened with a loss of -0.93% at $5.32 and touched an intraday high of $5.47, falling -13.22% against the last close of $5.37. The Lipocine Inc. in stock market went to a low of $4.91 during the session.
Lipocine Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
Lipocine Stock Price History Chart
675 Arapeen DriveSalt Lake City, UT 84108US
Contact #:801 994 7383
Sales or Revenue$554.99 Thousands
5Y Sales ChangeN/A
Fiscal Year EndsDec. 2022
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that has completed Phase II clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis; LPCN 1111, an oral prodrug of testosterone tridecanoate for once daily dosing, which has completed Phase II clinical trial in hypogonadal men; LPCN 1148, a novel prodrug of testosterone and testosterone laurate for the management of decompensated cirrhosis; LPCN 1154, an investigational new drug application to conduct a Phase 2 study in Postpartum depression; LPCN 2101 for women with epilepsy, which has completed pre-clinical study; and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. The company is headquartered in Salt Lake City, Utah.
Frequently Asked Questions
What is the current Lipocine Inc. (LPCN) stock price?
Lipocine Inc. (NASDAQ: LPCN) stock price is $4.66 in the last trading session. During the trading session, LPCN stock reached the peak price of $5.47 while $4.91 was the lowest point it dropped to. The percentage change in LPCN stock occurred in the recent session was -13.22% while the dollar amount for the price change in LPCN stock was -$0.71.
LPCN's industry and sector of operation?
The NASDAQ listed LPCN is part of Biotechnology industry that operates in the broader Healthcare sector. Lipocine Inc. , a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders.
Who are the executives of LPCN?
Ms. Krista Fogarty
Principal Accounting Officer & Corporation Controller
Dr. Mahesh V. Patel Ph.D.
Co-Founder, Interim Principal Financial Officer, Director, Pres & Chief Executive Officer
Mr. Logan Morse
Vice President of Sales, Marketing & Operations
Mr. Morgan R. Brown CPA, CPA, M.B.A., MBA
How LPCN did perform over past 52-week?
LPCN's closing price is 0.06% higher than its 52-week low of $3.3 where as its distance from 52-week high of $16.15 is -0.74%.
How many employees does LPCN have?
Number of LPCN employees currently stands at 17.00. LPCN operates from 675 Arapeen Drive</br>Salt Lake City, UT 84108</br>US.
Link for LPCN official website?
Official Website of LPCN is: https://www.lipocine.com
How do I contact LPCN?
LPCN could be contacted at phone #801 994 7383 and can also be accessed through its website. LPCN operates from 675 Arapeen Drive</br>Salt Lake City, UT 84108</br>US.
How many shares of LPCN are traded daily?
LPCN stock volume for the day was 15435.00 shares. The average number of LPCN shares traded daily for last 3 months was 17.54 Thousands.
What is the market cap of LPCN currently?
The market value of LPCN currently stands at $20.65 Million with its latest stock price at $4.66 and 90.19 Million of its shares outstanding.